BE688660A - - Google Patents

Info

Publication number
BE688660A
BE688660A BE688660DA BE688660A BE 688660 A BE688660 A BE 688660A BE 688660D A BE688660D A BE 688660DA BE 688660 A BE688660 A BE 688660A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE688660A publication Critical patent/BE688660A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50Three nitrogen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE688660D 1965-10-22 1966-10-21 BE688660A (en:Method)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CH506468A CH478818A (de) 1965-10-22 1965-10-22 Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
CH506368A CH478817A (de) 1965-10-22 1965-10-22 Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
CH506568A CH478819A (de) 1965-10-22 1965-10-22 Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
CH1463065A CH478816A (de) 1965-10-22 1965-10-22 Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen
CH1751468A CH499528A (de) 1965-10-22 1965-10-22 Verfahren zur Herstellung neuer Pyrimidine
CH1133066 1966-08-05

Publications (1)

Publication Number Publication Date
BE688660A true BE688660A (en:Method) 1967-04-21

Family

ID=27543760

Family Applications (1)

Application Number Title Priority Date Filing Date
BE688660D BE688660A (en:Method) 1965-10-22 1966-10-21

Country Status (11)

Country Link
US (1) US3503963A (en:Method)
BE (1) BE688660A (en:Method)
BR (1) BR6683919D0 (en:Method)
CH (5) CH499528A (en:Method)
DE (1) DE1670392A1 (en:Method)
FR (3) FR1500479A (en:Method)
GB (1) GB1135259A (en:Method)
IL (1) IL26473A (en:Method)
NL (1) NL6614961A (en:Method)
SE (1) SE345273B (en:Method)
SU (2) SU436494A3 (en:Method)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH485753A (de) * 1966-07-28 1970-02-15 Ciba Geigy Verfahren zur Herstellung neuer Aminopyrimidine
ES2295816T3 (es) 2003-01-14 2008-04-16 Arena Pharmaceuticals, Inc. Derivados arilo y heteroarilo 1,2,3-trisustituidos como moduladores del metabolismo, y profilaxis y tratamiento de transtornos relacionados con los mismos, tales como la diabetes y la hiperglucemia.
DE602004017703D1 (de) * 2003-02-24 2008-12-24 Arena Pharm Inc Phenyl- und pyridylpiperidinderivate als modulatoren des glucose-metabolismus
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
MXPA06014129A (es) * 2004-06-04 2007-03-07 Arena Pharm Inc Derivados de arilo y heteroarilo sustituidos como moduladores del metabolismo y profilaxis y tratamiento de trastornos relacionados con los mismos.
GT200500284A (es) * 2004-10-15 2006-03-27 Aventis Pharma Inc Pirimidinas como antagonistas del receptor de prostaglandina d2
MY148521A (en) * 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
ES2326391T3 (es) * 2005-09-16 2009-10-08 Arena Pharmaceuticals, Inc. Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo.
TW200811140A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
TW200811147A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
JP5856980B2 (ja) 2010-01-27 2016-02-10 アリーナ ファーマシューティカルズ, インコーポレイテッド (R)−2−(7−(4−シクロペンチル−3−(トリフルオロメチル)ベンジルオキシ)−1,2,3,4−テトラヒドロシクロペンタ[b]インドール−3−イル)酢酸およびその塩の調製のためのプロセス
WO2012040279A1 (en) 2010-09-22 2012-03-29 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
MX386419B (es) 2015-01-06 2025-03-18 Arena Pharm Inc Metodos de condiciones de tratamiento relacionadas con el receptor s1p1.
EP3310760B8 (en) 2015-06-22 2022-10-19 Arena Pharmaceuticals, Inc. Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid for use in s1p1 receptor-associated disorders
AU2018220521A1 (en) 2017-02-16 2019-09-05 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
ES2987794T3 (es) 2018-06-06 2024-11-18 Arena Pharm Inc Procedimientos de tratamiento de afecciones relacionadas con el receptor S1P1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB944443A (en:Method) * 1959-09-25 1900-01-01

Also Published As

Publication number Publication date
BR6683919D0 (pt) 1973-12-04
NL6614961A (en:Method) 1967-04-24
CH478819A (de) 1969-09-30
SU436494A3 (ru) 1974-07-15
CH478817A (de) 1969-09-30
FR6084M (en:Method) 1968-06-04
DE1670392A1 (de) 1970-07-16
CH499528A (de) 1970-11-30
GB1135259A (en) 1968-12-04
CH478816A (de) 1969-09-30
CH478818A (de) 1969-09-30
US3503963A (en) 1970-03-31
SU427513A3 (ru) 1974-05-05
FR6083M (en:Method) 1968-06-04
IL26473A (en) 1971-08-25
FR1500479A (fr) 1967-11-03
SE345273B (en:Method) 1972-05-23

Similar Documents

Publication Publication Date Title
FR6084M (en:Method)
JPS4410095Y1 (en:Method)
JPS4316880Y1 (en:Method)
JPS451340Y1 (en:Method)
JPS434208Y1 (en:Method)
JPS4329691Y1 (en:Method)
JPS447778Y1 (en:Method)
JPS5345500B1 (en:Method)
JPS4313941Y1 (en:Method)
JPS4210257Y1 (en:Method)
JPS4513693Y1 (en:Method)
JPS4516974Y1 (en:Method)
JPS453289Y1 (en:Method)
JPS47249Y1 (en:Method)
JPS47433Y1 (en:Method)
NL6612471A (en:Method)
BE664422A (en:Method)
BE671155A (en:Method)
BE670541A (en:Method)
NL6507112A (en:Method)
LU52131A1 (en:Method)
LU51971A1 (en:Method)
LU51606A1 (en:Method)
NL6601948A (en:Method)
BE667746A (en:Method)